Cancer-associated mutations in SF3B1 induce aberrant splicing of specific genes, such as DVL2, a regulator of Notch signaling, or disrupt interactions with other collaborating proteins, DDX42 and DDX46 [42,43]. Here, SF3B1 is linked to cancer.